Adenoid cystic carcinomas of the salivary gland, lacrimal gland, and breast are morphologically and genetically similar but have distinct microRNA expression profiles

Adenoid cystic carcinoma is among the most frequent malignancies in the salivary and lacrimal glands and has a grave prognosis characterized by frequent local recurrences, distant metastases, and tumor-related mortality. Conversely, adenoid cystic carcinoma of the breast is a rare type of triple-negative (estrogen and progesterone receptor, HER2) and basal-like carcinoma, which in contrast to other triple-negative and basal-like breast carcinomas has a very favorable prognosis. Irrespective of site, adenoid cystic carcinoma is characterized by gene fusions involving MYB, MYBL1, and NFIB, and the reason for the different clinical outcomes is unknown. In order to identify the molecular mechanisms underlying the discrepancy in clinical outcome, we characterized the phenotypic profiles, pattern of gene rearrangements, and global microRNA expression profiles of 64 salivary gland, 9 lacrimal gland, and 11 breast adenoid cystic carcinomas. All breast and lacrimal gland adenoid cystic carcinomas had triple-negative and basal-like phenotypes, while salivary gland tumors were indeterminate in 13% of cases. Aberrations in MYB and/or NFIB were found in the majority of cases in all three locations, whereas MYBL1 involvement was restricted to tumors in the salivary gland. Global microRNA expression profiling separated salivary and lacrimal gland adenoid cystic carcinoma from their respective normal glands but could not distinguish normal breast adenoid cystic carcinoma from normal breast tissue. Hierarchical clustering separated adenoid cystic carcinomas of salivary gland origin from those of the breast and placed lacrimal gland carcinomas in between these. Functional annotation of the microRNAs differentially expressed between salivary gland and breast adenoid cystic carcinoma showed these as regulating genes involved in metabolism, signal transduction, and genes involved in other cancers. In conclusion, microRNA dysregulation is the first class of molecules separating adenoid cystic carcinoma according to the site of origin. This highlights a novel venue for exploring the biology of adenoid cystic carcinoma.

[1]  John M S Bartlett,et al.  Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. , 2014, Archives of pathology & laboratory medicine.

[2]  B. Esmaeli,et al.  An Update on Tumors of the Lacrimal Gland. , 2017, Asia-Pacific journal of ophthalmology.

[3]  Ji-Ying Song,et al.  Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients , 2016, Cell reports.

[4]  C. von Buchwald,et al.  Human papillomavirus‐related carcinoma with adenoid cystic‐like features of the sinonasal tract: clinical and morphological characterization of six new cases , 2017, Histopathology.

[5]  N. Haass,et al.  NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF , 2017, EBioMedicine.

[6]  L. Richards,et al.  Nuclear factor one B (NFIB) encodes a subtype-specific tumour suppressor in glioblastoma , 2016, Oncotarget.

[7]  C K Osborne,et al.  Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Min Zhang,et al.  A unifying gene signature for adenoid cystic cancer identifies parallel MYB-dependent and MYB-independent therapeutic targets , 2014, Oncotarget.

[9]  Chao-Min Cheng,et al.  Up‐regulation of miR‐455‐5p by the TGF‐β–SMAD signalling axis promotes the proliferation of oral squamous cancer cells by targeting UBE2B , 2016, The Journal of pathology.

[10]  I. Wessel,et al.  Activation of the interleukin‐6/Janus kinase/STAT3 pathway in pleomorphic adenoma of the parotid gland , 2015, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[11]  R. Gronostajski,et al.  NFIB Regulates Embryonic Development of Submandibular Glands , 2015, Journal of dental research.

[12]  J. Bishop,et al.  The PRKD1 E710D hotspot mutation is highly specific in separating polymorphous adenocarcinoma of the palate from adenoid cystic carcinoma and pleomorphic adenoma on FNA , 2018, Cancer cytopathology.

[13]  T. Nielsen,et al.  Breast cancer subtypes and the risk of local and regional relapse. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  I. Wessel,et al.  Tumors of the sublingual gland: a national clinicopathologic study of 29 cases , 2016, European Archives of Oto-Rhino-Laryngology.

[15]  C. Moskaluk,et al.  Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms , 2011, Modern Pathology.

[16]  A. Gown,et al.  Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma , 2004, Clinical Cancer Research.

[17]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[18]  Qiong Shao,et al.  MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. , 2008, RNA.

[19]  W. Filipowicz,et al.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.

[20]  J. Reis-Filho,et al.  Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple‐negative and basal‐like breast cancers , 2012, The Journal of pathology.

[21]  S. Lam,et al.  Developmental transcription factor NFIB is a putative target of oncofetal miRNAs and is associated with tumour aggressiveness in lung adenocarcinoma , 2016, The Journal of pathology.

[22]  Karen Howe.  Extraction of miRNAs from Formalin-Fixed Paraffin-Embedded (FFPE) Tissues. , 2017, Methods in molecular biology.

[23]  H. Horlings,et al.  Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck , 2009, Proceedings of the National Academy of Sciences.

[24]  B. Perez-Ordonez,et al.  Mammary Analogue Secretory Carcinoma of Salivary Glands, Containing the ETV6-NTRK3 Fusion Gene: A Hitherto Undescribed Salivary Gland Tumor Entity , 2010, The American journal of surgical pathology.

[25]  C. Croce,et al.  microRNA involvement in human cancer. , 2012, Carcinogenesis.

[26]  J. Peterse,et al.  Refinement of breast cancer classification by molecular characterization of histological special types , 2008, The Journal of pathology.

[27]  G. Azabdaftari,et al.  Refinement of breast cancer classification by molecular characterization of histological special types , 2009 .

[28]  Shu Ichihara,et al.  Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists , 2011, Modern Pathology.

[29]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.

[30]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[31]  中尾 光輝,et al.  KEGG(Kyoto Encyclopedia of Genes and Genomes)〔和文〕 (特集 ゲノム医学の現在と未来--基礎と臨床) -- (データベース) , 2000 .

[32]  O. Mariani,et al.  Genomic landscape of adenoid cystic carcinoma of the breast , 2015, The Journal of pathology.

[33]  P. A. Futreal,et al.  Clinically significant copy number alterations and complex rearrangements of MYB and NFIB in head and neck adenoid cystic carcinoma , 2012, Genes, chromosomes & cancer.

[34]  P. Argani,et al.  MYB Labeling by Immunohistochemistry Is More Sensitive and Specific for Breast Adenoid Cystic Carcinoma than MYB Labeling by FISH , 2017, The American journal of surgical pathology.

[35]  J. Reis-Filho,et al.  Salivary duct carcinomas can be classified into luminal androgen receptor‐positive, HER2 and basal‐like phenotypes * , 2012, Histopathology.

[36]  P. Stephens,et al.  Comprehensive Genomic Profiling of Relapsed and Metastatic Adenoid Cystic Carcinomas by Next-generation Sequencing Reveals Potential New Routes to Targeted Therapies , 2014, The American journal of surgical pathology.

[37]  R. Weber,et al.  MicroRNA Profiling of Salivary Adenoid Cystic Carcinoma: Association of miR-17-92 Upregulation with Poor Outcome , 2013, PloS one.

[38]  Robin L. Jones,et al.  Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients , 2008, Breast Cancer Research and Treatment.

[39]  Irmtraud M. Meyer,et al.  The clonal and mutational evolution spectrum of primary triple-negative breast cancers , 2012, Nature.

[40]  B. Collins,et al.  MYB gene abnormalities t(6;9) in adenoid cystic carcinoma fine-needle aspiration biopsy using fluorescence in situ hybridization. , 2014, Archives of pathology & laboratory medicine.

[41]  Benjamin J. Raphael,et al.  The Mutational Landscape of Adenoid Cystic Carcinoma , 2013, Nature Genetics.

[42]  R. Anton,et al.  Adenoid cystic carcinoma of breast: Recent advances. , 2014, World Journal of Clinical Cases.

[43]  N. Schultz,et al.  Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer , 2016, Clinical Cancer Research.

[44]  Y. Adam,et al.  Adenoid cystic carcinoma of the breast. , 1974, American journal of surgery.

[45]  L. Wood,et al.  Whole-Genome Sequencing of Salivary Gland Adenoid Cystic Carcinoma , 2016, Cancer Prevention Research.

[46]  J. Reis-Filho,et al.  Adenoid cystic carcinomas of the breast and salivary glands (or ‘The strange case of Dr Jekyll and Mr Hyde’ of exocrine gland carcinomas) , 2010, Journal of Clinical Pathology.

[47]  M. Andreoli,et al.  Epidemiological Trends in Malignant Lacrimal Gland Tumors , 2015, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[48]  S. Lakhani,et al.  Salivary gland-like tumours of the breast: surgical and molecular pathology , 2003, Journal of clinical pathology.

[49]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[50]  Edith A Perez,et al.  MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer. , 2011, Trends in molecular medicine.

[51]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[52]  C. Croce.  Causes and consequences of microRNA dysregulation in cancer , 2009, Nature Reviews Genetics.

[53]  C. Godballe,et al.  Salivary adenoid cystic carcinoma in Denmark 1990-2005: Outcome and independent prognostic factors including the benefit of radiotherapy. Results of the Danish Head and Neck Cancer Group (DAHANCA). , 2015, Oral oncology.

[54]  S. Heegaard,et al.  Lacrimal gland ductal carcinomas: Clinical, Morphological and Genetic characterization and implications for targeted treatment , 2017, Acta ophthalmologica.

[55]  W. Thorstad,et al.  Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas , 2016, Cancer medicine.

[56]  Ellen T. Gelfand,et al.  The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.

[57]  Helen M. Moore,et al.  Biospecimen reporting for improved study quality (BRISQ) , 2011, Cancer cytopathology.

[58]  Timothy L Lash,et al.  Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank , 2010, Clinical epidemiology.

[59]  P. Homøe,et al.  Genomic profiling of a combined large cell neuroendocrine carcinoma of the submandibular gland. , 2016, Oncology reports.

[60]  E. Crawford,et al.  Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas , 2017, Modern Pathology.

[61]  B. Szekely,et al.  Breast- and Salivary Gland-Derived Adenoid Cystic Carcinomas: Potential Post-Transcriptional Divergencies. A Pilot Study Based on miRNA Expression Profiling of Four Cases and Review of the Potential Relevance of the Findings , 2014, Pathology & Oncology Research.

[62]  P. A. Futreal,et al.  Novel MYBL1 Gene Rearrangements with Recurrent MYBL1–NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations , 2015, Clinical Cancer Research.

[63]  Athanasios Fevgas,et al.  DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions , 2014, Nucleic Acids Res..

[64]  Y. Yatabe,et al.  MYB, MYBL1, MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma , 2017, Histopathology.

[65]  S. Heegaard,et al.  Adenoid cystic carcinoma of the lacrimal gland: MYB gene activation, genomic imbalances, and clinical characteristics. , 2013, Ophthalmology.

[66]  Artemis G. Hatzigeorgiou,et al.  DIANA-miRPath v3.0: deciphering microRNA function with experimental support , 2015, Nucleic Acids Res..

[67]  R. Weber,et al.  Detailed genome-wide SNP analysis of major salivary carcinomas localizes subtype-specific chromosome sites and oncogenes of potential clinical significance. , 2013, The American journal of pathology.

[68]  P. A. Futreal,et al.  Spatio-Temporal Genomic Heterogeneity, Phylogeny, and Metastatic Evolution in Salivary Adenoid Cystic Carcinoma , 2017, Journal of the National Cancer Institute.

[69]  Mahboob Ul Hussain.  Micro-RNAs (miRNAs): genomic organisation, biogenesis and mode of action. , 2012, Cell and tissue research.

[70]  H. Horlings,et al.  Genomic profiling of histological special types of breast cancer , 2013, Breast Cancer Research and Treatment.

[71]  D. Salomão,et al.  Adenoid cystic carcinoma of the lacrimal gland is frequently characterized by MYB rearrangement , 2017, Eye.

[72]  E. Sturgis,et al.  A comparison of the demographics, clinical features, and survival of patients with adenoid cystic carcinoma of major and minor salivary glands versus less common sites within the Surveillance, Epidemiology, and End Results registry , 2012, Cancer.

[73]  M. Stratton,et al.  Whole exome sequencing of adenoid cystic carcinoma. , 2013, The Journal of clinical investigation.